Market Overview:
The global genitourinary system treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of urinary tract infections (UTIs) and sexually transmitted diseases (STDs), rising awareness about available treatments, and growing demand for advanced therapies. By type, the global genitourinary system treatment market is segmented into over-the-counter (OTC) drugs and prescription drugs. The OTC drugs segment is expected to grow at a higher CAGR than the prescription drugs segment during the forecast period. This growth can be attributed to factors such as ease of availability and lower cost of OTC drugs as compared with prescription drugs. By application, the global genitourinary system treatment market is divided into hospitals and retail pharmacies segments.
Product Definition:
The genitourinary system is responsible for the removal of waste products from the body and the regulation of fluid balance. Treatment for disorders of this system may involve medication, surgery, or other treatments. The importance of genitourinary system treatment depends on the specific disorder.
OTC:
OTC stands for Over the Counter and is used to refer to drugs that are sold without a prescription. OTC drugs fall under the category of medications which can be taken directly by mouth. They do not require any medical prescription, unlike most other pharmaceutical products which are available only with a doctor’s prescription.
Rx Drugs:
Rx drugs are the ones purchased without a prescription and they are used to treat a specific disease or medical condition. The global genitourinary system treatment market is driven by factors such as growing prevalence of urological disorders, rising geriatric population base, increasing healthcare awareness among people, and rapid technological advancements in the pharmaceutical industry.
Application Insights:
The hospital application segment dominated the global genitourinary system treatment market in 2017. The growing prevalence of chronic diseases, such as diabetes and kidney stones, is expected to drive the hospital segment over the forecast period. Furthermore, an increase in healthcare expenditure coupled with a rise in geriatric population is anticipated to fuel growth during the study period.
The retail pharmacy application segment is expected to witness significant growth during the forecast period owing to rising awareness about available treatments among patients and their families. Moreover, increasing incidences of drug-resistant bacteria are driving demand for OTC drugs which can be purchased without a prescription from pharmacies or supermarkets.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high adoption rate for advanced treatment options, and favorable reimbursement scenario. The U.S., which is at the forefront, accounted for approximately 80% share in North America region due to higher healthcare expenditure and awareness about available treatments among patients as well as physicians.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income coupled with increasing government initiatives & programs aimed at improving healthcare infrastructure & facilities across emerging countries such as China.
Growth Factors:
- Increasing incidence of genitourinary system diseases such as urinary tract infection, prostate cancer, and bladder cancer.
- Growing demand for minimally invasive surgeries for the treatment of genitourinary system diseases.
- Rising awareness about the benefits of early diagnosis and treatment of genitourinary system diseases among patients and healthcare professionals.
- Technological advancements in the field of urology that are helping to improve the accuracy and efficiency of treatments for genitourinary system diseases.
Scope Of The Report
Report Attributes
Report Details
Report Title
Genitourinary System Treatment Market Research Report
By Type
OTC, Rx Drugs
By Application
Hospital, Retail Pharmacy
By Companies
Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, Allergan, GSK, Otsuka Pharmaceutical, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Genitourinary System Treatment Market Report Segments:
The global Genitourinary System Treatment market is segmented on the basis of:
Types
OTC, Rx Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Retail Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Daiichi Sankyo Company
- Pfizer
- Bayer
- Astellas Pharma
- Allergan
- GSK
- Otsuka Pharmaceutical
- Sanofi
Highlights of The Genitourinary System Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OTC
- Rx Drugs
- By Application:
- Hospital
- Retail Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genitourinary System Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genitourinary system treatment is a term used to describe the various treatments that are available for conditions that affect the urinary, reproductive, and sexual systems. These treatments can include surgery, medications, and other therapies.
Some of the major companies in the genitourinary system treatment market are Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, Allergan, GSK, Otsuka Pharmaceutical, Sanofi.
The genitourinary system treatment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Genitourinary System Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Genitourinary System Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Genitourinary System Treatment Market - Supply Chain
4.5. Global Genitourinary System Treatment Market Forecast
4.5.1. Genitourinary System Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Genitourinary System Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Genitourinary System Treatment Market Absolute $ Opportunity
5. Global Genitourinary System Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Genitourinary System Treatment Market Size and Volume Forecast by Type
5.3.1. OTC
5.3.2. Rx Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Genitourinary System Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Genitourinary System Treatment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Retail Pharmacy
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Genitourinary System Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Genitourinary System Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Genitourinary System Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Genitourinary System Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Genitourinary System Treatment Demand Share Forecast, 2019-2026
9. North America Genitourinary System Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Genitourinary System Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Genitourinary System Treatment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Retail Pharmacy
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Genitourinary System Treatment Market Size and Volume Forecast by Type
9.7.1. OTC
9.7.2. Rx Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Genitourinary System Treatment Demand Share Forecast, 2019-2026
10. Latin America Genitourinary System Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Genitourinary System Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Genitourinary System Treatment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Retail Pharmacy
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Genitourinary System Treatment Market Size and Volume Forecast by Type
10.7.1. OTC
10.7.2. Rx Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Genitourinary System Treatment Demand Share Forecast, 2019-2026
11. Europe Genitourinary System Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Genitourinary System Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Genitourinary System Treatment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Retail Pharmacy
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Genitourinary System Treatment Market Size and Volume Forecast by Type
11.7.1. OTC
11.7.2. Rx Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Genitourinary System Treatment Demand Share, 2019-2026
12. Asia Pacific Genitourinary System Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Genitourinary System Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Genitourinary System Treatment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Retail Pharmacy
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Genitourinary System Treatment Market Size and Volume Forecast by Type
12.7.1. OTC
12.7.2. Rx Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Genitourinary System Treatment Demand Share, 2019-2026
13. Middle East & Africa Genitourinary System Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Genitourinary System Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Genitourinary System Treatment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Retail Pharmacy
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Genitourinary System Treatment Market Size and Volume Forecast by Type
13.7.1. OTC
13.7.2. Rx Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Genitourinary System Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Genitourinary System Treatment Market: Market Share Analysis
14.2. Genitourinary System Treatment Distributors and Customers
14.3. Genitourinary System Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Daiichi Sankyo Company
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Astellas Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Allergan
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GSK
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Otsuka Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sanofi
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
